Citigroup
MDVL

Citigroup’s MedAvail Holdings, Inc. Common Stock MDVL Stock Holding History

Citigroup’s Portfolio MDVL Stock Details MDVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-22
Closed -$2K – 6481
2022
Q2 		$2K Buy
22
+11
+100% +$965 ﹤0.01% 5945
2022
Q1 		$1K Sell
11
-52
-83% -$3.12K ﹤0.01% 6240
2021
Q4 		$4K Buy
63
+35
+125% +$3.77K ﹤0.01% 5695
2021
Q3 		$4K Buy
28
+17
+155% +$5.16K ﹤0.01% 5621
2021
Q2 		$7K Sell
11
-375
-97% -$245K ﹤0.01% 5782
2021
Q1 		$270K Buy
386
+68
+21% +$48.9K ﹤0.01% 3840
2020
Q4 		$239K Buy
+318
New +$222K ﹤0.01% 4861
2016
Q1 		– Hold
0
– – – 7849
2015
Q4 		– Hold
0
– – – 7936

Other funds holding MDVL

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
AWGLSCP
ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $12.3M AUM 3.13% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
CI
Cigna Investments Bloomfield, Connecticut $773M AUM 44.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citigroup's MDVL Position: Q3 2022 in Review

Citigroup sold out of MedAvail Holdings, Inc. Common Stock (MDVL) in Q3 2022, closing a stake of 22 shares — an estimated $2K sold.

Citigroup first reported a position in MDVL in Q4 2020 and held it in 7 quarters. The position peaked at $270K in Q1 2021. 32 funds tracked by Wall St. Rank hold MDVL as of Q3 2022.

  • Citigroup reported no remaining MedAvail Holdings, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Citigroup sold 22 MedAvail Holdings, Inc. Common Stock shares in Q3 2022, an estimated $2K.
  • Citigroup first reported a position in MedAvail Holdings, Inc. Common Stock in Q4 2020 and held it in 7 quarters.
  • Citigroup's MedAvail Holdings, Inc. Common Stock position peaked at $270K in Q1 2021.
  • 32 funds tracked by Wall St. Rank held MedAvail Holdings, Inc. Common Stock as of Q3 2022.

Based on Citigroup's 13F filing for Q3 2022, filed 10 Nov 2022.